F13.1
Sedative, hypnotic or anxiolytic-related abuse
Clinical Classification Guidelines
Excludes Type 1
- sedative, hypnotic or anxiolytic-related dependence (F13.2-)
- sedative, hypnotic, or anxiolytic use, unspecified (F13.9-)
Medical Intelligence & Overview
Sedative, hypnotic, and anxiolytic drugs are commonly prescribed to manage anxiety, insomnia, and other conditions. However, misuse or abuse of these medications can lead to serious health issues. The ICD-10 code F13.1 refers to cases where these drugs are used in a manner that constitutes abuse. This condition highlights the importance of cautious prescribing and awareness of the risks associated with these medications.
Causes & Symptoms
Clinical Causes: Recreational use for their calming or sedative effects Self-medication for untreated mental health conditions such as anxiety and insomnia Potential dependency due to prolonged use or high doses Psychological factors, including a history of substance abuse or mental health disorders Social or environmental influences encouraging misuse
Key Symptoms: Repeated use of sedatives, hypnotics, or anxiolytics despite adverse effects Craving or strong desire to use the medication Difficulty controlling or reducing use Neglect of responsibilities and personal relationships Engagement in risky behaviors while under the influence Development of tolerance, requiring higher doses to achieve the same effect Withdrawal symptoms upon cessation, such as sweating, anxiety, or tremors
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a thorough medical and psychological evaluation. Healthcare providers typically review the patient's medication history, assess the pattern and severity of use, and identify any associated mental health issues. Diagnostic criteria for substance abuse disorders, including behaviors like neglecting responsibilities and continued use despite harm, assist in establishing the diagnosis.
Treatment Protocols: Detoxification under medical supervision to safely manage withdrawal symptoms Psychotherapy, such as cognitive-behavioral therapy (CBT), to address underlying issues and develop healthier coping strategies Medication-assisted treatment may be necessary to manage withdrawal or underlying mental health conditions Support groups and counseling to provide ongoing encouragement and accountability Monitoring and follow-up to prevent relapse and support long-term recovery
Clinical Advice & FAQs
Billing Guidance
Is F13.1 a billable ICD-10 code?
Yes, F13.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F13.1?
Clinical documentation must specify the nature of Sedative, hypnotic or anxiolytic-related abuse and any associated comorbidities for accurate reporting.
Cite this Clinical Reference